Banxa Reports Audited Full Year 2023 Financial Results

Written by Customer Service on December 27, 2023. Posted in Earnings Releases And Operating Results.

TORONTO and MELBOURNE, Australia, Dec. 27, 2023 (GLOBE NEWSWIRE) — Banxa Holdings Inc. (TSXV: BNXA) (OTCQX: BNXAF) (FSE: AC00) (“Banxa” or the “Company“) is pleased to report the audited full year ended June 30th, 2023 (“FY23”) financial results. The full results including Management Discussion & Analysis (“MD&A”) are available on Sedar. KEY FINANCIAL HIGHLIGHTS FY23 55% contraction in Total Transaction Volume (“TTV”) to AUD $646 million (USD $440 million), down from AUD $1.4 billion (USD $972 million), in line with overall decline in the crypto market 17% reduction in Gross Profit to AUD $17.2 million (USD $11.7 million), down from AUD $20.8 million (USD $14.2 million) due to contraction in TTV, but partially offset by increase in efficiencies Increase in Net Take Rate to 2.7%, up from 1.5% 46%...

Viveon Health Acquisition Corp. Receives Commencement of Delisting Notice From the NYSE

Written by Customer Service on December 27, 2023. Posted in Public Companies.

Atlanta, GA, Dec. 27, 2023 (GLOBE NEWSWIRE) — Viveon Health Acquisition Corp. (NYSE: VHAQ, VHAQW, VHAQR, VHAQU the “Company”) announces that, as previously disclosed in the Current Report on Form 8-K filed on December 26, 2023 with the United States Securities and Exchange Commission, the Company received a letter from the NYSE American LLC (“NYSE American” or the “Exchange”) on December 22, 2023, stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company’s Common Stock, Units and Rights (collectively, the “Securities”) pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination within 36 months of the effectiveness of its initial public offering registration statement, or such shorter period that the Company...

CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Written by Customer Service on December 27, 2023. Posted in Public Companies.

MINNEAPOLIS, Dec. 27, 2023 (GLOBE NEWSWIRE) — CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024. The Company is scheduled to present at 3:45pm Pacific Time the same day via webcast. A live audio webcast of the conference presentation will be available online at the investor relations page of the Company’s website at ir.cvrx.com. A replay of the webcast will be archived on the website for approximately 30 days. About CVRx, Inc. CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

Quipt Home Medical Corp. Announces Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus

Written by Customer Service on December 27, 2023. Posted in Public Companies.

CINCINNATI, Dec. 27, 2023 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it has filed a preliminary short form base shelf prospectus (the “Shelf Prospectus”) with the securities commissions in each of the provinces and territories of Canada, and a corresponding registration statement on Form F-10 (the “Registration Statement”) with the United States ‎Securities and Exchange Commission under the U.S./Canada Multijurisdictional Disclosure System‎. The Shelf Prospectus and Registration Statement, when made final and effective, will enable the Company to offer up to C$300,000,000 of common shares, preferred shares, debt securities, warrants to acquire any of the securities that are described...

Profound Medical Announces Proposed Public Offering of Common Shares

Written by Customer Service on December 27, 2023. Posted in Public Companies.

TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) — Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) is pleased to announce the commencement of an underwritten public offering in the United States of common shares (the “Common Shares”) in the capital of the Company (the “Offering”). The Company intends to file a preliminary prospectus supplement (the “Preliminary Supplement”) to its short form base shelf prospectus dated March 23, 2022 (the “Base Shelf Prospectus”) in the United States and Canada relating to the proposed Offering. The Company intends that the Offering will be priced in the context of the market, with such price and the total size of the Offering to be determined at the time of entering into an underwriting agreement with respect thereto. The Company expects to grant the underwriter for the Offering...

Plexus Provides Update on Unverified List Removal

Written by Customer Service on December 27, 2023. Posted in Public Companies.

NEENAH, WI, Dec. 27, 2023 (GLOBE NEWSWIRE) — Plexus Corp. (NASDAQ: PLXS) today received notification through official written correspondence from the U.S. Department of Commerce that its China subsidiary (“Plexus Xiamen”) will be removed from the Bureau of Industry and Security’s (“BIS”) Unverified List. Through no fault of Plexus or the BIS, a delay in the routine verification of a shipment to Plexus Xiamen occurred, which as a result of strong cooperation between the organizations has now been swiftly rectified. The Department of Commerce has commenced an administrative process to publish the removal of Plexus from the Unverified List in the Federal Register, which the company anticipates to occur in January 2024. Plexus remains committed to compliance with all applicable U.S. export control laws, and to working with BIS in a...

Horizon Aircraft and Pono Capital Three, Inc. Announce Effectiveness of Form S-4 Registration Statement and Date of Pono’s Special Meeting to Approve Business Combination

Written by Customer Service on December 27, 2023. Posted in Mergers And Acquisitions.

~ Special Meeting of Pono Capital Three, Inc. Shareholders to Approve Business Combination Scheduled for January 4, 2024 ~ ~ Upon Closing, the Combined Company is Expected to Trade on Nasdaq Under the Ticker “HOVR” ~ TORONTO, Canada and HONOLULU, Hawaii, Dec. 27, 2023 (GLOBE NEWSWIRE) — Robinson Aircraft Ltd., d/b/a Horizon Aircraft (“Horizon Aircraft” or the “Company”), a hybrid electric Vertical TakeOff and Landing (“eVTOL”) aircraft developer, and Pono Capital Three, Inc. (NASDAQ: PTHR, PTHRU and PTHRW) (“Pono”), a special purpose acquisition company, today announced that the Securities and Exchange Commission (“SEC”) has declared effective the Registration Statement on Form S-4 (“Registration Statement”) in connection with Horizon Aircraft and Pono’s proposed business combination (the “Business Combination”), which was previously...

Revelstone Capital Acquisition Corp. Adjourns Special Meeting to Approve Business Combination with Set Jet

Written by Customer Service on December 27, 2023. Posted in Mergers And Acquisitions.

~ Revelstone’s Special Meeting to Reconvene on Friday, December 29, 2023, at 12:00 pm EST ~ SCOTTSDALE, Ariz. and NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) — Revelstone Capital Acquisition Corp. (“RCAC”) (NASDAQ: RCAC), a publicly traded special purpose acquisition company, today announced that it has adjourned the meeting for shareholders to approve the proposed business combination (the “Business Combination”) with Set Jet, Inc. (“Set Jet”) to Friday, December 29, 2023 at 12:00 p.m. EST (the “BC Special Meeting”). The Meeting will still be held virtually via live webcast at https://www.cstproxy.com/revelstonecapital/sm2023. Shareholders of record as of the close of business on November 10, 2023 (the “Record Date”) are entitled to vote at the Meeting. Shareholders who have not yet done so are encouraged to vote as soon as possible....

Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was to Participate in the ICR Conference 2024

Written by Customer Service on December 27, 2023. Posted in Public Companies.

ATLANTA, Dec. 27, 2023 (GLOBE NEWSWIRE) — Oxford Industries, Inc. (NYSE: OXM) today announced the Company will be presenting at the ICR Conference 2024 being held at the JW Marriott Orlando Grande Lakes in Orlando, Florida. Tom Chubb, Chairman, CEO and President of Oxford will present at 10:00 a.m. Eastern Time on Tuesday, January 9, 2024. The presentation will be webcast and can be accessed via the Oxford website at www.oxfordinc.com. About OxfordOxford Industries, Inc., a leader in the apparel industry, owns and markets the distinctive Tommy Bahama®, Lilly Pulitzer®, Johnny Was®, Southern Tide®, The Beaufort Bonnet Company® and Duck Head® lifestyle brands. Oxford’s stock has traded on the New York Stock Exchange since 1964 under the symbol OXM. For more information, please visit Oxford’s website at www.oxfordinc.com. Contact: Brian...

ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference

Written by Customer Service on December 27, 2023. Posted in Public Companies.

SAN DIEGO, Dec. 27, 2023 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer and chair of the board, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024, beginning at approximately 2:15 p.m. (Pacific Standard Time) at the Westin St. Francis in San Francisco, CA. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following thirty (30) days. About ResMedAt ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our...

Day: December 27, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice